263 related articles for article (PubMed ID: 20943659)
1. The 1.5 Å crystal structure of human receptor for advanced glycation endproducts (RAGE) ectodomains reveals unique features determining ligand binding.
Park H; Adsit FG; Boyington JC
J Biol Chem; 2010 Dec; 285(52):40762-70. PubMed ID: 20943659
[TBL] [Abstract][Full Text] [Related]
2. The Trp triad within the V-domain of the receptor for advanced glycation end products modulates folding, stability and ligand binding.
Indurthi VSK; Jensen JL; Leclerc E; Sinha S; Colbert CL; Vetter SW
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31912881
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for ligand recognition and activation of RAGE.
Koch M; Chitayat S; Dattilo BM; Schiefner A; Diez J; Chazin WJ; Fritz G
Structure; 2010 Oct; 18(10):1342-52. PubMed ID: 20947022
[TBL] [Abstract][Full Text] [Related]
4. Structural insights into the binding of the human receptor for advanced glycation end products (RAGE) by S100B, as revealed by an S100B-RAGE-derived peptide complex.
Jensen JL; Indurthi VS; Neau DB; Vetter SW; Colbert CL
Acta Crystallogr D Biol Crystallogr; 2015 May; 71(Pt 5):1176-83. PubMed ID: 25945582
[TBL] [Abstract][Full Text] [Related]
5. The Structure of the RAGE:S100A6 Complex Reveals a Unique Mode of Homodimerization for S100 Proteins.
Yatime L; Betzer C; Jensen RK; Mortensen S; Jensen PH; Andersen GR
Structure; 2016 Dec; 24(12):2043-2052. PubMed ID: 27818100
[TBL] [Abstract][Full Text] [Related]
6. Structural insights into the oligomerization mode of the human receptor for advanced glycation end-products.
Yatime L; Andersen GR
FEBS J; 2013 Dec; 280(24):6556-68. PubMed ID: 24119142
[TBL] [Abstract][Full Text] [Related]
7. Structural and functional insights into RAGE activation by multimeric S100B.
Ostendorp T; Leclerc E; Galichet A; Koch M; Demling N; Weigle B; Heizmann CW; Kroneck PM; Fritz G
EMBO J; 2007 Aug; 26(16):3868-78. PubMed ID: 17660747
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE).
Xie J; Reverdatto S; Frolov A; Hoffmann R; Burz DS; Shekhtman A
J Biol Chem; 2008 Oct; 283(40):27255-69. PubMed ID: 18667420
[TBL] [Abstract][Full Text] [Related]
9. A fragment-based approach to discovery of Receptor for Advanced Glycation End products inhibitors.
Kozlyuk N; Gilston BA; Salay LE; Gogliotti RD; Christov PP; Kim K; Ovee M; Waterson AG; Chazin WJ
Proteins; 2021 Nov; 89(11):1399-1412. PubMed ID: 34156100
[TBL] [Abstract][Full Text] [Related]
10. S100B interaction with the receptor for advanced glycation end products (RAGE): a novel receptor-mediated mechanism for myocyte apoptosis postinfarction.
Tsoporis JN; Izhar S; Leong-Poi H; Desjardins JF; Huttunen HJ; Parker TG
Circ Res; 2010 Jan; 106(1):93-101. PubMed ID: 19910580
[TBL] [Abstract][Full Text] [Related]
11. Interaction of S100A13 with C2 domain of receptor for advanced glycation end products (RAGE).
Rani SG; Sepuru KM; Yu C
Biochim Biophys Acta; 2014 Sep; 1844(9):1718-28. PubMed ID: 24982031
[TBL] [Abstract][Full Text] [Related]
12. Binding of S100 proteins to RAGE: an update.
Leclerc E; Fritz G; Vetter SW; Heizmann CW
Biochim Biophys Acta; 2009 Jun; 1793(6):993-1007. PubMed ID: 19121341
[TBL] [Abstract][Full Text] [Related]
13. Circulating Ligands of the Receptor for Advanced Glycation End Products and the Soluble Form of the Receptor Modulate Cardiovascular Cell Apoptosis in Diabetes.
Tsoporis JN; Hatziagelaki E; Gupta S; Izhar S; Salpeas V; Tsiavou A; Rigopoulos AG; Triantafyllis AS; Marshall JC; Parker TG; Rizos IK
Molecules; 2020 Nov; 25(22):. PubMed ID: 33182705
[TBL] [Abstract][Full Text] [Related]
14. Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches.
Xie J; Burz DS; He W; Bronstein IB; Lednev I; Shekhtman A
J Biol Chem; 2007 Feb; 282(6):4218-31. PubMed ID: 17158877
[TBL] [Abstract][Full Text] [Related]
15. Blocking the interface region amongst S100A6 and RAGE V domain via S100B protein.
Sung HY; Dowarha D; Chou RH; Yu C
Biochem Biophys Res Commun; 2020 Dec; 533(3):332-337. PubMed ID: 32958253
[TBL] [Abstract][Full Text] [Related]
16. A capture method based on the VC1 domain reveals new binding properties of the human receptor for advanced glycation end products (RAGE).
Degani G; Altomare AA; Colzani M; Martino C; Mazzolari A; Fritz G; Vistoli G; Popolo L; Aldini G
Redox Biol; 2017 Apr; 11():275-285. PubMed ID: 28013188
[TBL] [Abstract][Full Text] [Related]
17. Activation of RAGE induces elevated O2- generation by mononuclear phagocytes in diabetes.
Ding Y; Kantarci A; Hasturk H; Trackman PC; Malabanan A; Van Dyke TE
J Leukoc Biol; 2007 Feb; 81(2):520-7. PubMed ID: 17095613
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into calcium-bound S100P and the V domain of the RAGE complex.
Penumutchu SR; Chou RH; Yu C
PLoS One; 2014; 9(8):e103947. PubMed ID: 25084534
[TBL] [Abstract][Full Text] [Related]
19. Tranilast Blocks the Interaction between the Protein S100A11 and Receptor for Advanced Glycation End Products (RAGE) V Domain and Inhibits Cell Proliferation.
Huang YK; Chou RH; Yu C
J Biol Chem; 2016 Jul; 291(27):14300-14310. PubMed ID: 27226584
[TBL] [Abstract][Full Text] [Related]
20. S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release.
Bianchi R; Kastrisianaki E; Giambanco I; Donato R
J Biol Chem; 2011 Mar; 286(9):7214-26. PubMed ID: 21209080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
